Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › Daiichi Sankyo Submits Supplemental New Drug Application In Japan For LIXIANA (Edoxaban Tosilate Hydrate) For New Indications

 

Daiichi Sankyo Submits Supplemental New Drug Application In Japan For LIXIANA (Edoxaban Tosilate Hydrate) For New Indications

2013-12-30 06:22:57| drugdiscoveryonline News Articles

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has submitted a supplemental New Drug Application (NDA) for its oral, once-daily direct factor Xa-inhibitor LIXIANA® (Edoxaban Tosilate Hydrate) for review by the Japanese Ministry of Health, Labour and Welfare

Tags: new japan application drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»

05.11 Registration Now Open for RadTech 2025 05.11 Atlantic Tropical Weather Outlook 05.11 Eastern North Pacific Tropical Weather Outlook 05.11 Tropical Storm Rafael Graphics 05.11 Tropical Storm Rafael Public Advisory Number 7A 05.11 Summary for Tropical Storm Rafael (AT3/AL182024) 05.11 Vodafone-Three merger could get green light, watchdog says 05.11 Altice USA residential video RGUs down 77,000 in 3Q 2024 More »